Trial intelligence / Profile preview

Non-inferiority study of malathion 0.5% lotion versus Prioderm in the treatment of head lice

2007-001844-34Phase 3Completed

Sponsor
Pierre Fabre Laboratories
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of malathion in pediculosis capitis (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Primary efficacy endpoint. Started Aug 2007; status: completed.

02

Drugs

malathion
03

Conditions

pediculosis capitis

Beyond the preview

Go deeper on 2007-001844-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001844-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call